CAMBRIDGE, UK, May 8 – Britain’s Wellcome Trust has launched a print advertising campaign to promote the public human genome databases, including the UK-based Ensembl database, after a survey revealed that only half of the biomedical scientists were aware of the freely available offerings.

The Wellcome Trust, which provides the majority of the funding for Ensembl, said the campaign is designed to drum up interest in public genome data in order to help spur advances in medical research.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.